More than 1,700 personal injury lawsuits are pending against pharmaceutical company Boehringer Ingelheim in Illinois. Plaintiffs filing in the in federal multidistrict litigation allege that the company\u2019s blood-thinning medication Pradaxa caused internal bleeding.<\/p>\n
These lawsuits are part of multidistrict litigation in U.S. District Court, Southern District of Illinois. On November 4, the court established a protocol for selecting bellwether cases, directing both sides to select up to three lawsuits as possible candidates. In January 2014, the court will select four of those cases for the first bellwether trials, which are scheduled to commence in August 2014.<\/p>\n
According to court records, at least 1,767 lawsuits are pending in the litigation. The complaints allege that Boehringer Ingelheim failed to adequately warn doctors and patients about internal bleeding as a side effect of Pradaxa and about the lack of an available antidote.<\/p>\n
The Food and Drug Administration recorded more than 582 deaths and 3,292 reports of other (more…)<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":" More than 1,700 personal injury lawsuits are pending against pharmaceutical company Boehringer Ingelheim in Illinois. Plaintiffs filing in the in federal multidistrict litigation allege that the company\u2019s blood-thinning medication Pradaxa caused internal bleeding. These lawsuits are part of multidistrict litigation…<\/span><\/p>\n